# Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)

> **NCT00209404** · PHASE4 · COMPLETED · sponsor: **GE Healthcare** · enrollment: 50 (—)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Iodixanol 320 mg I/Ml

## Key facts

- **NCT ID:** NCT00209404
- **Lead sponsor:** GE Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 50 (—)
- **Last updated:** 2007-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209404, "Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00209404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*